Author

Jonathan H. Shrimp

National Center for Advancing Translational SciencesORCID 0000-0001-9872-942XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jonathan H. Shrimp1 paper · National Institutes of Health

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Alex D. WhiteiD· 1 shared Bryan L. RothiD· 1 shared Hugh C. HemmingsiD· 1 shared James IngleseiD· 1 shared Jayme L. DahliniD· 1 shared Karl F. HeroldiD· 1 shared Olaf Sparre AnderseniD· 1 shared Patricia K. DranchakiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alex D. WhiteORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintOct 23, 2023

Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity

Richard T. Eastman, Radda Rusinova, Karl F. Herold…·Jayme L. Dahlin

This study shows ivermectin reduces SARS-CoV-2 viral burden in vitro but at concentrations that also cause cytotoxicity, suggesting its antiviral effect may be due to nonspecific membrane perturbation rather than specific antiviral activity.

3 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky